Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect

Fig. 7

The figure shows the cell viability percent of different empty niosome dilutions on MCF10A (a), SKBR3 and 4T1 cell lines (b), and cell viability percent of MELITTin-loaded niosome concentrations on healthy MCF10A cell line (c). Data are shown as mean ± SEM. The mean values with different superscript letters are significantly different (P ≤ 0.05)

Back to article page